NAFDAC issues public alert on UK legal claims against Johnson & Johnson baby powder

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert over ongoing legal actions in the United Kingdom involving Johnson & Johnson’s talc-based baby powder and alleged cancer risks linked to asbestos contamination.

In Public Alert No. 043/2025, NAFDAC disclosed that more than 3,000 claimants in the UK have filed lawsuits alleging that long-term use of Johnson & Johnson’s baby powder exposed them to asbestos, a known carcinogen.

The claimants reportedly linked the product to serious health conditions, including ovarian cancer, lung cancer and mesothelioma.

NAFDAC explained that talc is a naturally occurring mineral often found close to asbestos deposits, making strict quality control and testing essential to ensure cosmetic products are asbestos-free.

The agency noted that the World Health Organisation (WHO) classifies asbestos as a Group 1 human carcinogen and that it is banned or tightly regulated in many countries.

The agency further observed that Johnson & Johnson baby powder is widely used globally, including in Nigeria, particularly by women and infants for hygiene and cosmetic purposes.

According to NAFDAC, exposure to asbestos-contaminated talcum powder has been associated with cancers of the lungs, larynx and ovaries, as well as mesothelioma.

However, the agency clarified that there is currently no conclusive regulatory determination establishing a direct link between asbestos contamination in talc-based cosmetic products and cancer in consumers.

NAFDAC stressed that the UK legal cases remain allegations subject to judicial determination.

It also reiterated that talc may be used in cosmetic products provided it meets approved safety and purity standards, adding that the agency continues to monitor scientific evidence and global developments concerning talc safety.

The agency advised consumers to use cosmetic products strictly according to label instructions and to seek medical attention if they experience health issues that may be related to product use.

NAFDAC reaffirmed its commitment to protecting public health and said it would continue post-market surveillance to ensure the safety and quality of regulated products in Nigeria.

Consumers were encouraged to report any adverse reactions or safety concerns related to talc-based products to the nearest NAFDAC office, through the agency’s e-reporting platforms on its website, via the Med Safety App, or by email at pharmacovigilance@nafdac.gov.ng.